APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimicrobial Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antimicrobial Therapeutics Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchAntimicrobial Therapeutics Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimicrobial Therapeutics Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Antimicrobial Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimicrobial Therapeutics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimicrobial Therapeutics Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Antimicrobial Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antimicrobial Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antimicrobial Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antimicrobial Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antimicrobial Therapeutics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antimicrobial Therapeutics market include Sanofi, Merck & Co Inc., Pfizer Inc., GlaxoSmithKline plc and Gilead Sciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Antimicrobial Therapeutics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antimicrobial Therapeutics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antimicrobial Therapeutics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Antimicrobial Therapeutics market.

Antimicrobial Therapeutics Segment by Company

Sanofi

Merck & Co Inc.

Pfizer Inc.

GlaxoSmithKline plc

Gilead Sciences, Inc.

Antimicrobial Therapeutics Segment by Type

Personal

Hospital

Clinic

Other

Antimicrobial Therapeutics Segment by Application

Antifungal

Antibacterial

Antiparasitic

Antiviral

Antimicrobial Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antimicrobial Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Antimicrobial Therapeutics key companies, revenue, market share, and recent developments.

3. To split the Antimicrobial Therapeutics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Antimicrobial Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antimicrobial Therapeutics significant trends, drivers, influence factors in global and regions.

6. To analyze Antimicrobial Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimicrobial Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimicrobial Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimicrobial Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antimicrobial Therapeutics industry.

Chapter 3: Detailed analysis of Antimicrobial Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Antimicrobial Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Antimicrobial Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antimicrobial Therapeutics Industry Trends Table 2. Antimicrobial Therapeutics Industry Drivers Table 3. Antimicrobial Therapeutics Industry Opportunities and Challenges Table 4. Antimicrobial Therapeutics Industry Restraints Table 5. Global Antimicrobial Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antimicrobial Therapeutics Revenue Share by Company (2021-2026) Table 7. Global Antimicrobial Therapeutics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Antimicrobial Therapeutics Key Company Manufacturing Base & Headquarters Table 9. Global Antimicrobial Therapeutics Company, Product Type & Application Table 10. Global Antimicrobial Therapeutics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Antimicrobial Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Personal Table 15. Significant Companies of Hospital Table 16. Significant Companies of Clinic Table 17. Significant Companies of Other Table 18. Global Antimicrobial Therapeutics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Antimicrobial Therapeutics Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Antimicrobial Therapeutics Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Antimicrobial Therapeutics Sales Value Share by Type (2021-2026) Table 22. Global Antimicrobial Therapeutics Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Antifungal Table 24. Significant Companies of Antibacterial Table 25. Significant Companies of Antiparasitic Table 26. Significant Companies of Antiviral Table 27. Global Antimicrobial Therapeutics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Antimicrobial Therapeutics Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Antimicrobial Therapeutics Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Antimicrobial Therapeutics Sales Value Share by Application (2021-2026) Table 31. Global Antimicrobial Therapeutics Sales Value Share by Application (2027-2032) Table 32. Global Antimicrobial Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Antimicrobial Therapeutics Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Antimicrobial Therapeutics Sales Value Share by Region (2021-2026) Table 35. Global Antimicrobial Therapeutics Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Antimicrobial Therapeutics Sales Value Share by Region (2027-2032) Table 37. Global Antimicrobial Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Antimicrobial Therapeutics Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Antimicrobial Therapeutics Sales Value Market Share by Country (2021-2026) Table 40. Global Antimicrobial Therapeutics Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Antimicrobial Therapeutics Sales Value Market Share by Country (2027-2032) Table 42. Sanofi Company Information Table 43. Sanofi Business Overview Table 44. Sanofi Antimicrobial Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Sanofi Antimicrobial Therapeutics Product Portfolio Table 46. Sanofi Recent Development Table 47. Merck & Co Inc. Company Information Table 48. Merck & Co Inc. Business Overview Table 49. Merck & Co Inc. Antimicrobial Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Merck & Co Inc. Antimicrobial Therapeutics Product Portfolio Table 51. Merck & Co Inc. Recent Development Table 52. Pfizer Inc. Company Information Table 53. Pfizer Inc. Business Overview Table 54. Pfizer Inc. Antimicrobial Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Pfizer Inc. Antimicrobial Therapeutics Product Portfolio Table 56. Pfizer Inc. Recent Development Table 57. GlaxoSmithKline plc Company Information Table 58. GlaxoSmithKline plc Business Overview Table 59. GlaxoSmithKline plc Antimicrobial Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. GlaxoSmithKline plc Antimicrobial Therapeutics Product Portfolio Table 61. GlaxoSmithKline plc Recent Development Table 62. Gilead Sciences, Inc. Company Information Table 63. Gilead Sciences, Inc. Business Overview Table 64. Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Gilead Sciences, Inc. Antimicrobial Therapeutics Product Portfolio Table 66. Gilead Sciences, Inc. Recent Development Table 67. Research Programs/Design for This Report Table 68. Authors List of This Report Table 69. Secondary Sources Table 70. Primary Sources List of Figures Figure 1. Antimicrobial Therapeutics Product Image Figure 2. Global Antimicrobial Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimicrobial Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Antimicrobial Therapeutics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Personal Image Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Antimicrobial Therapeutics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Antimicrobial Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Antimicrobial Therapeutics Sales Value Share by Type (2021-2032) Figure 14. Antifungal Image Figure 15. Antibacterial Image Figure 16. Antiparasitic Image Figure 17. Antiviral Image Figure 18. Global Antimicrobial Therapeutics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Antimicrobial Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Antimicrobial Therapeutics Sales Value Share by Application (2021-2032) Figure 21. Global Antimicrobial Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Antimicrobial Therapeutics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Antimicrobial Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 24. North America Antimicrobial Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Antimicrobial Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Antimicrobial Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Antimicrobial Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Antimicrobial Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Antimicrobial Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 30. South America Antimicrobial Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Antimicrobial Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Antimicrobial Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Personal
  • Hospital
  • Clinic
  • Other
Applications
  • Antifungal
  • Antibacterial
  • Antiparasitic
  • Antiviral
Companies covered
  • Sanofi
  • Merck & Co Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Gilead Sciences, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antimicrobial Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antimicrobial Therapeutics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Antimicrobial Therapeutics Market Dynamics
  1. 2.1 Antimicrobial Therapeutics Industry Trends
  2. 2.2 Antimicrobial Therapeutics Industry Drivers
  3. 2.3 Antimicrobial Therapeutics Industry Opportunities and Challenges
  4. 2.4 Antimicrobial Therapeutics Industry Restraints
3 Antimicrobial Therapeutics Market by Company
  1. 3.1 Global Antimicrobial Therapeutics Company Revenue Ranking in 2025
  2. 3.2 Global Antimicrobial Therapeutics Revenue by Company (2021-2026)
  3. 3.3 Global Antimicrobial Therapeutics Company Ranking (2024-2026)
  4. 3.4 Global Antimicrobial Therapeutics Company Manufacturing Base and Headquarters
  5. 3.5 Global Antimicrobial Therapeutics Company Product Type and Application
  6. 3.6 Global Antimicrobial Therapeutics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Antimicrobial Therapeutics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Antimicrobial Therapeutics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Antimicrobial Therapeutics Market by Type
  1. 4.1 Antimicrobial Therapeutics Type Introduction
  2. 4.1.1 Personal
  3. 4.1.2 Hospital
  4. 4.1.3 Clinic
  5. 4.1.4 Other
  6. 4.2 Global Antimicrobial Therapeutics Sales Value by Type
  7. 4.2.1 Global Antimicrobial Therapeutics Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Antimicrobial Therapeutics Sales Value by Type (2021-2032)
  9. 4.2.3 Global Antimicrobial Therapeutics Sales Value Share by Type (2021-2032)
5 Antimicrobial Therapeutics Market by Application
  1. 5.1 Antimicrobial Therapeutics Application Introduction
  2. 5.1.1 Antifungal
  3. 5.1.2 Antibacterial
  4. 5.1.3 Antiparasitic
  5. 5.1.4 Antiviral
  6. 5.2 Global Antimicrobial Therapeutics Sales Value by Application
  7. 5.2.1 Global Antimicrobial Therapeutics Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antimicrobial Therapeutics Sales Value by Application (2021-2032)
  9. 5.2.3 Global Antimicrobial Therapeutics Sales Value Share by Application (2021-2032)
6 Antimicrobial Therapeutics Regional Value Analysis
  1. 6.1 Global Antimicrobial Therapeutics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antimicrobial Therapeutics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Antimicrobial Therapeutics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Antimicrobial Therapeutics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antimicrobial Therapeutics Sales Value (2021-2032)
  7. 6.3.2 North America Antimicrobial Therapeutics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Antimicrobial Therapeutics Sales Value (2021-2032)
  10. 6.4.2 Europe Antimicrobial Therapeutics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Antimicrobial Therapeutics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Antimicrobial Therapeutics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Antimicrobial Therapeutics Sales Value (2021-2032)
  16. 6.6.2 South America Antimicrobial Therapeutics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Antimicrobial Therapeutics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Antimicrobial Therapeutics Sales Value Share by Country, 2025 VS 2032
7 Antimicrobial Therapeutics Country-level Value Analysis
  1. 7.1 Global Antimicrobial Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antimicrobial Therapeutics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Antimicrobial Therapeutics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Antimicrobial Therapeutics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Antimicrobial Therapeutics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Antimicrobial Therapeutics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Antimicrobial Therapeutics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Antimicrobial Therapeutics Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck & Co Inc.
  8. 8.2.1 Merck & Co Inc. Company Information
  9. 8.2.2 Merck & Co Inc. Business Overview
  10. 8.2.3 Merck & Co Inc. Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co Inc. Antimicrobial Therapeutics Product Portfolio
  12. 8.2.5 Merck & Co Inc. Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Antimicrobial Therapeutics Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 GlaxoSmithKline plc
  20. 8.4.1 GlaxoSmithKline plc Company Information
  21. 8.4.2 GlaxoSmithKline plc Business Overview
  22. 8.4.3 GlaxoSmithKline plc Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline plc Antimicrobial Therapeutics Product Portfolio
  24. 8.4.5 GlaxoSmithKline plc Recent Developments
  25. 8.5 Gilead Sciences, Inc.
  26. 8.5.1 Gilead Sciences, Inc. Company Information
  27. 8.5.2 Gilead Sciences, Inc. Business Overview
  28. 8.5.3 Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gilead Sciences, Inc. Antimicrobial Therapeutics Product Portfolio
  30. 8.5.5 Gilead Sciences, Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst